• About
  • News
  • Team
  • Carriers

News

News List
ARTI-401 Selected for KDDF Drug Candidate Project
Jul, 2026
artiCure and TFBS Bioscience Join Forces in Virus Manufacturing to Advance Development of Innovative Cancer Gene Therapy
Aug, 2025
구혁채 과기부 1차관, 'R&D 촉매' 연구산업 현장서 발전방향 논의
Aug, 2025
셀리드, 알티큐어와 CDMO 통합 솔루션 구축 MOU
Jun, 2025
[a:rti]Cure and nSAGE have signed an MOU to jointly develop the next-generation solid tumor treatment CAR-X using each company's platform technology.
Oct, 2024
ARTI-101 Selected for KDDF Preclinical Project
May, 2024
ARTI-101 Selected for KDDF Drug Candidate Project
May, 2022

Search

Articure
Representative : Yeon-Soo Kim Business Registration Number : 548-87-00954 Main Phone : +82-10-8367-7335 E-Mail : articure@icgm.kr
Address : Room 301, W1-1, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, South Korea.
Copyright © 2026 Articure. All rights reserved.
Designed By ADS&SOFT.
Scroll
유전자의약 이노베이션센터